vs

Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and JBG SMITH Properties (JBGS). Click either name above to swap in a different company.

CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $127.6M, roughly 1.9× JBG SMITH Properties). CROSS COUNTRY HEALTHCARE INC runs the higher net margin — -35.0% vs -35.7%, a 0.7% gap on every dollar of revenue. On growth, JBG SMITH Properties posted the faster year-over-year revenue change (-2.5% vs -23.6%). Over the past eight quarters, JBG SMITH Properties's revenue compounded faster (-6.3% CAGR vs -21.0%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.

CCRN vs JBGS — Head-to-Head

Bigger by revenue
CCRN
CCRN
1.9× larger
CCRN
$236.8M
$127.6M
JBGS
Growing faster (revenue YoY)
JBGS
JBGS
+21.1% gap
JBGS
-2.5%
-23.6%
CCRN
Higher net margin
CCRN
CCRN
0.7% more per $
CCRN
-35.0%
-35.7%
JBGS
Faster 2-yr revenue CAGR
JBGS
JBGS
Annualised
JBGS
-6.3%
-21.0%
CCRN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCRN
CCRN
JBGS
JBGS
Revenue
$236.8M
$127.6M
Net Profit
$-82.9M
$-45.5M
Gross Margin
Operating Margin
-30.2%
-47.5%
Net Margin
-35.0%
-35.7%
Revenue YoY
-23.6%
-2.5%
Net Profit YoY
-2109.7%
24.0%
EPS (diluted)
$-2.56
$-0.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCRN
CCRN
JBGS
JBGS
Q4 25
$236.8M
$127.6M
Q3 25
$250.1M
$123.9M
Q2 25
$274.1M
$126.5M
Q1 25
$293.4M
$120.7M
Q4 24
$309.9M
$130.8M
Q3 24
$315.1M
$136.0M
Q2 24
$339.8M
$135.3M
Q1 24
$379.2M
$145.2M
Net Profit
CCRN
CCRN
JBGS
JBGS
Q4 25
$-82.9M
$-45.5M
Q3 25
$-4.8M
$-28.6M
Q2 25
$-6.7M
$-19.2M
Q1 25
$-490.0K
$-45.7M
Q4 24
$-3.8M
$-59.9M
Q3 24
$2.6M
$-27.0M
Q2 24
$-16.1M
$-24.4M
Q1 24
$2.7M
$-32.3M
Gross Margin
CCRN
CCRN
JBGS
JBGS
Q4 25
Q3 25
20.4%
Q2 25
20.4%
Q1 25
20.0%
Q4 24
Q3 24
20.4%
Q2 24
20.8%
Q1 24
20.4%
Operating Margin
CCRN
CCRN
JBGS
JBGS
Q4 25
-30.2%
-47.5%
Q3 25
-2.4%
-27.5%
Q2 25
-2.1%
-18.4%
Q1 25
-0.3%
-44.7%
Q4 24
-1.1%
-53.6%
Q3 24
0.9%
-22.4%
Q2 24
-5.7%
-24.3%
Q1 24
0.8%
-30.1%
Net Margin
CCRN
CCRN
JBGS
JBGS
Q4 25
-35.0%
-35.7%
Q3 25
-1.9%
-23.1%
Q2 25
-2.4%
-15.2%
Q1 25
-0.2%
-37.9%
Q4 24
-1.2%
-45.8%
Q3 24
0.8%
-19.8%
Q2 24
-4.7%
-18.0%
Q1 24
0.7%
-22.2%
EPS (diluted)
CCRN
CCRN
JBGS
JBGS
Q4 25
$-2.56
$-0.76
Q3 25
$-0.15
$-0.48
Q2 25
$-0.20
$-0.29
Q1 25
$-0.02
$-0.56
Q4 24
$-0.13
$-0.70
Q3 24
$0.08
$-0.32
Q2 24
$-0.47
$-0.27
Q1 24
$0.08
$-0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCRN
CCRN
JBGS
JBGS
Cash + ST InvestmentsLiquidity on hand
$108.7M
$75.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$322.8M
$1.2B
Total Assets
$449.0M
$4.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCRN
CCRN
JBGS
JBGS
Q4 25
$108.7M
$75.3M
Q3 25
$99.1M
$64.4M
Q2 25
$81.2M
$61.4M
Q1 25
$80.7M
$81.3M
Q4 24
$81.6M
$145.8M
Q3 24
$64.0M
$137.0M
Q2 24
$69.6M
$163.5M
Q1 24
$5.2M
$220.5M
Stockholders' Equity
CCRN
CCRN
JBGS
JBGS
Q4 25
$322.8M
$1.2B
Q3 25
$408.1M
$1.2B
Q2 25
$412.2M
$1.3B
Q1 25
$418.2M
$1.6B
Q4 24
$419.0M
$1.8B
Q3 24
$424.7M
$1.9B
Q2 24
$433.3M
$2.0B
Q1 24
$462.4M
$2.1B
Total Assets
CCRN
CCRN
JBGS
JBGS
Q4 25
$449.0M
$4.4B
Q3 25
$538.2M
$4.4B
Q2 25
$553.8M
$4.5B
Q1 25
$576.2M
$4.7B
Q4 24
$589.3M
$5.0B
Q3 24
$597.4M
$5.2B
Q2 24
$602.9M
$5.3B
Q1 24
$648.4M
$5.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCRN
CCRN
JBGS
JBGS
Operating Cash FlowLast quarter
$18.2M
$73.3M
Free Cash FlowOCF − Capex
$16.1M
FCF MarginFCF / Revenue
6.8%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$40.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCRN
CCRN
JBGS
JBGS
Q4 25
$18.2M
$73.3M
Q3 25
$20.1M
$8.9M
Q2 25
$4.2M
$18.8M
Q1 25
$5.7M
$12.9M
Q4 24
$24.2M
$129.4M
Q3 24
$7.5M
$26.4M
Q2 24
$82.4M
$23.8M
Q1 24
$6.0M
$37.0M
Free Cash Flow
CCRN
CCRN
JBGS
JBGS
Q4 25
$16.1M
Q3 25
$17.9M
Q2 25
$2.3M
Q1 25
$3.8M
Q4 24
$21.7M
Q3 24
$6.3M
Q2 24
$79.6M
Q1 24
$3.8M
FCF Margin
CCRN
CCRN
JBGS
JBGS
Q4 25
6.8%
Q3 25
7.2%
Q2 25
0.8%
Q1 25
1.3%
Q4 24
7.0%
Q3 24
2.0%
Q2 24
23.4%
Q1 24
1.0%
Capex Intensity
CCRN
CCRN
JBGS
JBGS
Q4 25
0.9%
Q3 25
0.9%
Q2 25
0.7%
Q1 25
0.6%
Q4 24
0.8%
Q3 24
0.4%
Q2 24
0.8%
Q1 24
0.6%
Cash Conversion
CCRN
CCRN
JBGS
JBGS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
2.92×
Q2 24
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCRN
CCRN

Temporary Staffing Services$189.6M80%
Physician Staffing$42.5M18%
Other Services$4.7M2%

JBGS
JBGS

Segment breakdown not available.

Related Comparisons